Literature DB >> 6527259

Concentration-dependent enhancement of 1-dodecylazacycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide.

D S Chow, I Kaka, T I Wang.   

Abstract

The enhancing effect of 1-dodecylazacycloheptan-2-one (I) on the penetration kinetics of triamcinolone acetonide (II) and the possible mechanisms of enhancement were studied using nonreinforced and reinforced silicone elastomer membranes and full-thickness hairless mouse skin as penetration barriers. Lactam I, at test concentrations of 0.1-10%, significantly promoted the extent and the rate of penetration of the acetonide II. Regardless of the barrier used the effect was concentration dependent, but the penetration profiles were different. The enhancement with synthetic membranes was attributed solely to the effect of lactam I doubling the diffusion constant (D), which resulted in the increase of the permeability coefficient (Kp) and the shortening of the lag time (tau); the partition coefficient (Km), however, was not affected. With mouse skin, I exerted effects on both D and Km. Compound I potentiated the retention of II in skin (a reservoir effect) about sevenfold; however, the enhancing reservoir effect was independent of the concentration of I. Pretreatment with I was found to be more efficient than the coapplication of I and II in the vehicle. The coexistence of I and II was not required for the enhancement, and the reduced enhancing efficiency suggested an interaction between I and II in the vehicle. Penetration impedance was observed after exposure to I with skin, but not with synthetic membranes. Interaction of I with the skin component, or the coexistence of I and II in the skin, could be responsible for such an impedance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527259     DOI: 10.1002/jps.2600731234

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Effects of transdermal penetration enhancers on the permeability of shed snakeskin.

Authors:  T Itoh; L Wasinger; T M Turunen; J H Rytting
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

2.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

3.  Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin.

Authors:  T Itoh; J Xia; R Magavi; T Nishihata; J H Rytting
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

4.  Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen.

Authors:  Nahla Salah Barakat
Journal:  AAPS PharmSciTech       Date:  2010-07-23       Impact factor: 3.246

5.  Disposition and metabolic profiling of the penetration enhancer Azone. I. In vitro studies: urinary profiles of hamster, rat, monkey, and man.

Authors:  J W Wiechers; B F Drenth; F A Adolfsen; L Prins; R A de Zeeuw
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  The topical anti-inflammatory and analgesic properties of bromfenac in rodents.

Authors:  J C Nolan; L E Wagner; C E Gathright; D J Stephens; L F Sancilio
Journal:  Agents Actions       Date:  1988-08

7.  Effect of Different Skin Penetration Promoters in Halobetasol Propionate Permeation and Retention in Human Skin.

Authors:  Paulina Carvajal-Vidal; Mireia Mallandrich; María Luisa García; Ana Cristina Calpena
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.